Cardlytics, Inc.

For the period ended Apr 12, 2024. Filed Apr 12, 2024.

About this filing

What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.

Apr 12, 2024 · Filed Apr 12, 2024

CDLX$1.95-11.0%Stored close · as of Nov 6, 2026

See the whole filing, with its images and exhibits

APPENDIX - A

Reconciliation from GAAP Gross Profit to Adjusted Contribution (in thousands):

	Year Ended December 31,
	2023	2022	2021	2020
Revenue	$309,204	$298,542	$267,116	$186,892
Minus:
Partner Share and other third-party costs	150,578	155,507	141,273	109,308
Delivery costs	28,248	30,403	22,503	14,310
Gross Profit	130,378	112,632	103,340	63,274
Plus:
Delivery costs	28,248	30,403	22,503	14,310
Non-cash equity expense included in FI Share	—	—	—	—
Deferred implementation costs	—	—	3,785	4,598
Adjusted Contribution	$158,626	$143,035	$129,628	$82,182

Reconciliation from GAAP Net Loss to Adjusted EBITDA (in thousands):

	Year Ended December 31,
	2023	2022	2021	2020
Net Loss	$(134,702)	$(465,264)	$(128,565)	$(55,422)
Plus:
Interest expense, net	2,336	2,556	12,563	3,048
Depreciation and amortization	26,460	37,544	29,871	7,826
Stock-based compensation expense	40,980	44,686	50,264	32,396
Acquisition, integration and divestiture (benefits) costs	(6,313)	(2,874)	24,372	—
Change in fair value of contingent consideration	1,246	(128,174)	1,374	—
Foreign currency (gain) loss	(3,304)	6,376	1,267	(1,549)
Impairment of goodwill and intangible assets	70,518	453,288	—	—
Loss on divestiture	6,550	—	—	—
Restructuring and reduction of force	—	8,139	713	1,323
Income tax benefit	—	(1,446)	(7,864)	—
Deferred implementation costs	—	—	3,785	4,598
Adjusted EBITDA	$3,771	$(45,169)	$(12,220)	$(7,780)

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.